PLIANT THERAPT (PLRX)
(Delayed Data from NSDQ)
$1.43 USD
-0.06 (-4.03%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.45 +0.02 (1.40%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Pliant Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PLRX 1.43 -0.06(-4.03%)
Will PLRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PLRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PLRX
PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know
PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know
PLRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About PLIANT THERAPT (PLRX) Rating Upgrade to Buy
Other News for PLRX
Technical picture remains unchanged for PLRX after it falls 4.03% on September 19
PLRX's price rises by 2.05% on September 18, though its technical setup remains stable.
PLRX forms MACD Bearish Centerline Cross on September 17
50 Day Moving Average Resistance appears for PLRX after 0.0% move
Is PLRX preparing to trend lower? 20 Day Moving Average Resistance shows up after dropping 3.77%